CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 12,810
-410 (-3.10%)
Jul 14, 2026, 3:30 PM KST
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 70.28 billion as of July 14, 2026. Its market cap has decreased by -44.55% in one year.
Market Cap
70.28B
Enterprise Value
n/a
Revenue
159.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,810.00
Market Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 70.28B, an increase of 592.62%. That is a compound annual growth rate of 8.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 70.28B | -37.05% |
| Dec 30, 2025 | 111.64B | -7.50% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AptaBio Therapeutics | 123.47B |
| Kyongbo Pharmaceutical | 123.12B |
| SAMSUNG PHARM. Co., LTD. | 122.83B |
| HLB Pharmaceutical | 120.34B |
| Jeil Pharma Holdings | 102.55B |
| HANDOK | 102.50B |
| Enzychem Lifesciences | 76.86B |
| Kukje Pharma | 70.35B |